ARCHIVES

EU Gives Marketing Approval For HBV Sequencing Test

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

New Chemotherapy, Other Modality Progress Described

March 30, 1979

CCOPs At Six Months: Sme Exceeding Patient Goals, Most Are Meeting Schedules

March 30, 1984

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

Vanderbilt-Ingram Cancer Center Wins NCI’s Comprehensive Designation.

March 16, 2001